FindTrial
Sign In

Ayurvedic drops/syp in fever

EVALUATION OF ANTIPYRETIC EFFECT OF PARPATA ARKA IN PAEDIATRIC AGE GROUP - A RANDOMISED CONTROLLED CLINICAL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031604
Enrollment
30
Registered
2021-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50-D89- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Interventions

Intervention1: Parpata arka: This formulation is mentioned in Ravankruta arkaprakash for treatment of fever. route is oral AGE DOSE 3yrs 3.75ml 4yrs 5ml 5yrs 6.25ml 6yrs 7.5ml 7yrs 8.75ml 8yr

Sponsors

Dr Kavita Sangale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children of either sex between the age groups 3-16 yrs. 2. Those fulfilling diagnostic criteria.

Exclusion criteria

Exclusion criteria: Any febrile condition of children requiring an immediate intervention depending on history and general condition at the point of examination as found by investigator will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Parpata arka may be effective in reducing fever.Timepoint: 4 HOURS—

Secondary

MeasureTime frame
Parpata arka and paracetamol are equally effective as anti-pyretic in paediatric febrile conditions.Timepoint: 18 months—

Countries

India

Contacts

Public ContactDr Veena K H

Shri BMK Ayurved Mahavidyalaya

kavitakuranagi@gmail.com8105408991

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026